CDCA7L - middle region Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-CDCA7L - middle region antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityCDCA7L - middle region
Clonepolyclonal
Host SpeciesRabbit
Reactive Speciescow, dog, guinea pig, horse, human, mouse, rabbit, rat, yeast, zebrafish
Isotypen/a
Formataffinity purified
Size0.1 mL
Concentrationn/a
ApplicationsWestern Blot (WB)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionThis is a rabbit polyclonal antibody against CDCA7L. It was validated on Western Blot using a cell lysate as a positive control.Target Description: CDCA7L plays a role in transcriptional regulation as a repressor that inhibits monoamine oxidase A (MAOA) activity and gene expression by binding to the promoter.CDCA7L plays an important oncogenic role in mediating the full transforming effect of MYC in medulloblastoma cells. CDCA7L is involved in apoptotic signaling pathways. CDCA7L may act downstream of P38-kinase and BCL-2, but upstream of CASP3/caspase-3 as well as CCND1/cyclin D1 and E2F1.
ImmunogenImmunogen: The immunogen is a synthetic peptide directed towards the middle region of human CDCA7L
Other Names[cell division cycle-associated 7-like protein isoform 2; Cell division cycle-associated 7-like protein; cell division cycle-associated 7-like protein; cell division cycle associated 7 like; Protein JPO2; Transcription factor RAM2]
Gene, Accession #[CDCA7L], Gene ID: 55536, NCBI: NP_001120842, UniProt: B3KTR5
Catalog #MBS3213280
Price$335
Order / More InfoCDCA7L - middle region Antibody from MYBIOSOURCE INC.
Product Specific Referencesn/a
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.